1. Home
  2. CDP vs CORT Comparison

CDP vs CORT Comparison

Compare CDP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

N/A

Current Price

$32.39

Market Cap

3.6B

Sector

Real Estate

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$43.56

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDP
CORT
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
CDP
CORT
Price
$32.39
$43.56
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$34.00
$96.50
AVG Volume (30 Days)
794.3K
1.9M
Earning Date
04-27-2026
05-04-2026
Dividend Yield
3.77%
N/A
EPS Growth
8.94
N/A
EPS
1.34
0.82
Revenue
$763,923,000.00
$761,407,000.00
Revenue This Year
$1.84
$26.08
Revenue Next Year
$3.62
$31.04
P/E Ratio
$24.11
$53.27
Revenue Growth
1.41
12.79
52 Week Low
$25.21
$28.66
52 Week High
$32.82
$91.00

Technical Indicators

Market Signals
Indicator
CDP
CORT
Relative Strength Index (RSI) 58.84 64.59
Support Level $31.28 $32.95
Resistance Level $32.76 $47.06
Average True Range (ATR) 0.56 1.71
MACD 0.14 0.51
Stochastic Oscillator 89.95 88.86

Price Performance

Historical Comparison
CDP
CORT

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: